Home » The cumulative number of mucormycosis cases in India exceeds 20,000, and related medicines were once in short supply

The cumulative number of mucormycosis cases in India exceeds 20,000, and related medicines were once in short supply

by admin









</p> <p> The cumulative number of mucormycosis cases in India exceeds 20,000, and related medicines were once in short supply<br />

Home> News> Current Affairs

The total number of mucormycosis cases in India exceeded 20,000, and related medicines were once in short supply

2021-06-04 18:04

Source: Securities Times

Author: Song Tenghu

Securities Times

Song Tenghu

2021-06-04 18:04

Securities Times reported that according to CCTV News citing Indian media reports on the 4th, Indian official statistics show that the cumulative number of mucormycosis cases in India has exceeded 20,000 so far. The continuous increase in the number of cases of mucormycosis has also led to a shortage of related medicines for the treatment of the disease. The Indian government has recently been adopting measures such as stepping up domestic production and importing related drugs from abroad to meet current challenges. Indian health experts call mucormycosis an “epidemic disease”. Its symptoms include headaches, nosebleeds, hemoptysis, facial numbness and swelling, blurred vision, and difficulty breathing, with a high fatality rate.

Disclaimer: The Securities Times strives for truthful and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk accordingly.

  • Securities Times APP
  • WeChat public account


  • 3307987

    The total number of mucormycosis cases in India exceeded 20,000, and related medicines were once in short supply

    6880

    current events

    news

    1429

    Song Tenghu

    2021-06-04

    .

    See also  The howls of Tehran: a cry of freedom rises from the rooftops in the dark

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy